International Journal of Clinical Practice10.1111/j.1742-1241.2005.00622.x20055991055-1062Targeted therapies for non-small cell lung cancerJ Spicer, P Harper,
Cancer Research and Treatment10.4143/crt.2022.0782022542315-329Challenges in the Use of Targeted Therapies in Non–Small Cell Lung CancerJoel Rivera-Concepcion, Dipesh Uprety, Alex A. Adjei,,
Clinical Lung Cancer10.1016/s1525-7304(11)70540-x200242124“Targeted” Therapies for non—small-Cell Lung CancerAlex A. Adjei,
Clinical Lung Cancer10.3816/clc.2006.s.00720068S6Therapeutic Ratio of Targeted Therapies in Non–Small-Cell Lung CancerDavid R. Gandara,
Lung Cancer10.1016/j.lungcan.2009.10.0122010673257-274Targeted therapies for non-small cell lung cancerWolfram C.M. Dempke, Tamas Suto, Martin Reck,
Clinical Lung Cancer10.3816/clc.2002.n.021200242111-123Promising Developments in Targeted Therapies for non–small-Cell Lung CancerDesirée Hao, Manuel Hidalgo,
Current Biomarker Findings10.2147/cbf.s2017920127Biomarkers for the targeted therapies of non-small cell lung cancerAntonio Rossi, Galetta
Clinical Lung Cancer10.1016/j.cllc.2013.03.0052013145467-472Molecularly Targeted Therapies in Locally Advanced Non–Small-Cell Lung CancerSiddhartha Devarakonda, Daniel Morgensztern, Ramaswamy Govindan,
Seminars in Oncology10.1053/j.seminoncol.2005.12.0072006339-16Use of Novel Second-Line Targeted Therapies in Non–Small Cell Lung CancerErminia Massarelli, Roy S. Herbst,
Lung Cancer10.1016/s0169-5002(03)00155-7200341115-121Targeted therapies for stage III non-small cell lung cancer: integration in the combined modality settingEverett E. Vokes, Hak Choy,